EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2

Qing Xia, Guanghua Liu, Wenbo Lin, Jin Zhang

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23824 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Qing Xia and 3 co-authors. Institution: Department of General Surgery, Hwa Mei Hospital (Ningbo No.2 Hospital), University of Chinese Academy of Sciences, Ningbo, China. Major MEDLINE topics: MicroRNAs, Liver Neoplasms, Neoplastic Stem Cells, Drug Resistance, Neoplasm. Cited 7 times so far (Crossref); 34 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: This work was supported by the grant from the National Natural Science Foundation of China (81572791); Ningbo Clinical Research Center for Digestive System Tum….

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cancer stem cells (CSCs) are involved in the regulation of tumor initiation, progression, recurrence, and chemoresistance. However, the role of microRNAs (miRNAs) in liver CSCs has not been fully understood. Here we show that miR‐2117 is downregulated in liver CSCs and predicts the poor prognosis of hepatocellular carcinoma (HCC) patients. Biofunction studies found that knockdown miR‐2117 facilitates liver CSCs self‐renewal and tumorigenesis. Conversely, forced miR‐2117 expression suppresses liver CSCs self‐renewal and tumorigenesis. Mechanistically, we find that transcription factor SOX2 is required for miR‐2117‐mediated liver CSCs expansion. The correlation between miR‐2117 and SOX2 was confirmed in human HCC tissues. More importantly, miR‐2117 overexpression HCC cells are more sensitive to CDDP treatment. Analysis of patients' cohort further demonstrates that miR‐2117 may predict transcatheter arterial chemoembolization benefits in HCC patients. Our findings revealed the crucial role of miR‐2117 in liver CSCs expansion, rendering miR‐2117 as an optimal therapeutic target for HCC.

Subjects

MeSH terms (MEDLINE)

MicroRNAsLiver NeoplasmsNeoplastic Stem CellsDrug Resistance, NeoplasmCarcinoma, HepatocellularSOXB1 Transcription FactorsGene Expression Regulation, NeoplasticHumansAnimalsMiceCell ProliferationCell Line, TumorPrognosisMaleFemaleCisplatinMice, Nude

Author keywords

SOX2TACEhepatocellular carcinomaliver cancer stem cellmiR‐2117

Substances

MicroRNAsSOXB1 Transcription FactorsSOX2 protein, humanCisplatin

Authors and institutions

  • Department of General Surgery, Hwa Mei Hospital (Ningbo No.2 Hospital), University of Chinese Academy of Sciences, Ningbo, China.
  • Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, China.
  • Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo, China.
  • Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Interventional Radiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
  • Department of Orthopedic Surgery, Changzheng Hospital, Navy Medical University, Shanghai, China.

Funding

  • This work was supported by the grant from the National Natural Science Foundation of China (81572791); Ningbo Clinical Research Center for Digestive System Tum…

Cite

APA

Xia, Q., Liu, G., Lin, W., & Zhang, J. (2025). microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23824

Vancouver

Xia Q, Liu G, Lin W, Zhang J. microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23824

BibTeX
@article{Xia2025,
  author = {Xia, Qing and Liu, Guanghua and Lin, Wenbo and Zhang, Jin},
  title = {microRNA‐2117 Negatively Regulates Liver Cancer Stem Cells Expansion and Chemoresistance Via Targeting SOX2},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23824}
}
Start for free →